PALI
Palisade Bio Inc
NASDAQ: PALI · HEALTHCARE · BIOTECHNOLOGY
$1.19
+0.00% today
Updated 2026-10-29
Market cap
$231.78M
P/E ratio
2.22
P/S ratio
463.56x
EPS (TTM)
$0.60
Dividend yield
—
52W range
$1 – $3
Volume
3.0M
Palisade Bio Inc (PALI) Insider transactions
Net insider activity
Net buying (26,751,483 shares)
Buy transactions
65
Sell transactions
35
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-19 | FINLEY, JOHN DAVID | Director, CEO, CFO | Buy | 88,400 | — | — |
| 2026-07-09 | BALTERA, ROBERT JR. | Director | Buy | 25,000 | $1.96 | $48900.00 |
| 2026-07-08 | BALTERA, ROBERT JR. | Director | Buy | 20,000 | $1.99 | $39798.00 |
| 2026-07-07 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Sale | 51,880 | $2.05 | $106535.58 |
| 2026-07-07 | FINLEY, JOHN DAVID | Director, CEO, CFO | Sale | 133 | — | — |
| 2026-07-07 | FINLEY, JOHN DAVID | Director, CEO, CFO | Sale | 146,798 | $2.07 | $303343.39 |
| 2026-07-07 | FINLEY, JOHN DAVID | Director, CEO, CFO | Buy | 133 | $0.70 | $93.10 |
| 2026-07-07 | BALTERA, ROBERT JR. | Director | Buy | 30,000 | $2.03 | $61044.00 |
| 2026-07-06 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Sale | 131,167 | — | — |
| 2026-07-06 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Buy | 131,167 | — | — |
| 2026-07-06 | FINLEY, JOHN DAVID | Director, CEO, CFO | Sale | 335,167 | — | — |
| 2026-07-06 | FINLEY, JOHN DAVID | Director, CEO, CFO | Buy | 335,167 | — | — |
| 2026-07-06 | BALTERA, ROBERT JR. | Director | Buy | 20,000 | $2.05 | $41040.00 |
| 2026-07-02 | BALTERA, ROBERT JR. | Director | Buy | 10,000 | $1.98 | $19800.00 |
| 2026-07-01 | BALTERA, ROBERT JR. | Director | Buy | 20,000 | $1.98 | $39600.00 |
| 2026-06-10 | ZWICK, JORDAN MICHAEL | Director | Buy | 336,904 | — | — |
| 2026-06-10 | WILLIAMS, DONALD ALLEN | Director | Sale | 60,666 | — | — |
| 2026-06-10 | WILLIAMS, DONALD ALLEN | Director | Buy | 1,498,900 | — | — |
| 2026-06-10 | WILLIAMS, DONALD ALLEN | Director | Buy | 60,666 | — | — |
| 2026-06-10 | WEI, BINXIAN | Director | Sale | 20,200 | — | — |
| 2026-06-10 | WEI, BINXIAN | Director | Buy | 592,300 | — | — |
| 2026-06-10 | WEI, BINXIAN | Director | Buy | 20,200 | — | — |
| 2026-06-10 | CHUANG, EMIL | Director | Sale | 20,200 | — | — |
| 2026-06-10 | CHUANG, EMIL | Director | Buy | 592,300 | — | — |
| 2026-06-10 | CHUANG, EMIL | Director | Buy | 20,200 | — | — |
| 2026-06-10 | BALTERA, ROBERT JR. | Director | Buy | 336,904 | — | — |
| 2026-02-12 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Sale | 1,989 | $1.75 | $3480.75 |
| 2026-02-12 | FINLEY, JOHN DAVID | Director, CEO, CFO | Sale | 3,896 | $1.75 | $6818.00 |
| 2026-02-11 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Sale | 8,000 | — | — |
| 2026-02-11 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Buy | 8,000 | — | — |
| 2026-02-11 | FINLEY, JOHN DAVID | Director, CEO, CFO | Sale | 13,333 | — | — |
| 2026-02-11 | FINLEY, JOHN DAVID | Director, CEO, CFO | Buy | 13,333 | — | — |
| 2026-02-09 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Buy | 787,000 | — | — |
| 2026-02-09 | FINLEY, JOHN DAVID | Director, CEO, CFO | Buy | 2,011,000 | — | — |
| 2026-01-16 | WILLIAMS, DONALD ALLEN | Director | Buy | 5,000 | $1.67 | $8356.00 |
| 2026-01-09 | WILLIAMS, DONALD ALLEN | Director | Buy | 5,000 | $1.88 | $9400.00 |
| 2025-10-06 | WILLIAMS, DONALD ALLEN | Director | Buy | 1,538,700 | — | — |
| 2025-10-06 | WILLIAMS, DONALD ALLEN | Director | Buy | 182,000 | — | — |
| 2025-10-06 | WEI, BINXIAN | Director | Buy | 510,700 | — | — |
| 2025-10-06 | WEI, BINXIAN | Director | Buy | 60,600 | — | — |
| 2025-10-06 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Buy | 7,665,800 | — | — |
| 2025-10-06 | FINLEY, JOHN DAVID | Director, CEO, CFO | Buy | 9,179,400 | — | — |
| 2025-10-06 | CHUANG, EMIL | Director | Buy | 510,700 | — | — |
| 2025-10-06 | CHUANG, EMIL | Director | Buy | 60,600 | — | — |
| 2025-09-04 | WILLIAMS, DONALD ALLEN | Director | Buy | 64,400 | — | — |
| 2025-09-04 | WEI, BINXIAN | Director | Buy | 18,800 | — | — |
| 2025-09-04 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Buy | 289,000 | — | — |
| 2025-09-04 | FINLEY, JOHN DAVID | Director, CEO, CFO | Buy | 323,400 | — | — |
| 2025-09-04 | CHUANG, EMIL | Director | Buy | 18,800 | — | — |
| 2025-07-18 | CHUANG, EMIL | Director | Buy | 8,000 | — | — |
| 2025-02-11 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Buy | 29,000 | — | — |
| 2025-02-11 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Buy | 24,000 | — | — |
| 2025-02-11 | FINLEY, JOHN DAVID | Director, CEO, CFO | Buy | 47,000 | — | — |
| 2025-02-11 | FINLEY, JOHN DAVID | Director, CEO, CFO | Buy | 40,000 | — | — |
| 2024-11-21 | WILLIAMS, DONALD ALLEN | Director | Buy | 388 | — | — |
| 2024-11-21 | WEI, BINXIAN | Director | Buy | 388 | — | — |
| 2024-07-11 | WILLIAMS, DONALD ALLEN | Director | Buy | 2,100 | — | — |
| 2024-07-11 | WEI, BINXIAN | Director | Buy | 2,100 | — | — |
| 2024-07-11 | FISCHBEIN, MARGERY B. | Director | Buy | 2,100 | — | — |
| 2024-06-11 | WILLIAMS, DONALD ALLEN | Director | Buy | 340 | — | — |
| 2024-06-11 | WEI, BINXIAN | Director | Buy | 465 | — | — |
| 2024-05-28 | WILLIAMS, DONALD ALLEN | Director | Buy | 1,000 | $4.86 | $4863.00 |
| 2024-05-28 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Sale | 2,735 | — | — |
| 2024-05-28 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Sale | 1,555 | — | — |
| 2024-05-28 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Buy | 2,735 | — | — |
| 2024-05-28 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Buy | 1,555 | — | — |
| 2024-05-28 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Sale | 810 | $4.76 | $3855.60 |
| 2024-05-28 | JONES, MITCHELL LAWRENCE | Chief Medical Officer | Sale | 461 | $4.76 | $2194.36 |
| 2024-05-28 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Sale | 3,335 | — | — |
| 2024-05-28 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Sale | 2,111 | — | — |
| 2024-05-28 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Sale | 1,622 | — | — |
| 2024-05-28 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Buy | 3,335 | — | — |
| 2024-05-28 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Buy | 2,111 | — | — |
| 2024-05-28 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Buy | 1,622 | — | — |
| 2024-05-28 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Sale | 959 | $4.76 | $4564.84 |
| 2024-05-28 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Sale | 607 | $4.76 | $2889.32 |
| 2024-05-28 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Sale | 467 | $4.76 | $2222.92 |
| 2024-05-24 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Buy | 1,000 | $4.81 | $4810.00 |
| 2024-05-20 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Buy | 666 | $4.97 | $3311.68 |
| 2024-05-06 | JONES, MITCHELL LAWRENCE | CEO, CFO, Director | Sale | 304 | — | — |
| 2024-05-06 | JONES, MITCHELL LAWRENCE | CEO, CFO, Director | Sale | 156 | — | — |
| 2024-05-06 | JONES, MITCHELL LAWRENCE | CEO, CFO, Director | Buy | 304 | — | — |
| 2024-05-06 | JONES, MITCHELL LAWRENCE | CEO, CFO, Director | Buy | 156 | — | — |
| 2024-05-06 | JONES, MITCHELL LAWRENCE | CEO, CFO, Director | Sale | 90 | $8.46 | $761.40 |
| 2024-05-06 | JONES, MITCHELL LAWRENCE | CEO, CFO, Director | Sale | 47 | $8.46 | $397.62 |
| 2024-05-06 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Sale | 232 | — | — |
| 2024-05-06 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Sale | 211 | — | — |
| 2024-05-06 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Buy | 232 | — | — |
| 2024-05-06 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Buy | 211 | — | — |
| 2024-05-06 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Sale | 67 | $8.46 | $566.82 |
| 2024-05-06 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Sale | 61 | $8.46 | $516.06 |
| 2024-03-11 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Sale | 5,558 | — | — |
| 2024-03-11 | FINLEY, JOHN DAVID | Director, CEO, CFO, Director | Buy | 5,558 | — | — |
| 2024-02-09 | NEAL, JAMES R | Director | Sale | 5,820 | — | — |
| 2024-02-09 | NEAL, JAMES R | Director | Sale | 5,100 | — | — |
| 2024-02-09 | NEAL, JAMES R | Director | Buy | 5,820 | — | — |
| 2024-02-09 | NEAL, JAMES R | Director | Buy | 5,100 | — | — |
| 2024-02-09 | NEAL, JAMES R | Director | Buy | 12,160 | — | — |
| 2024-02-09 | NEAL, JAMES R | Director | Sale | 6,880 | — | — |
| 2024-02-08 | TRENSCHEL, ROBERT J. | Director | Sale | 5,820 | — | — |
Frequently asked questions
Are PALI insiders buying or selling?
Over the transactions on record, PALI insiders have been net buyers, with about $438146.66 in stock sold across 35 sales, against 12 open-market purchases.
Does insider selling at PALI mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which PALI insiders are selling the most?
Recent selling is concentrated in a few names. FINLEY, JOHN DAVID accounts for the largest share on record, with about $320921.35 sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.